The loss of ARNT/HIF1β in male pancreatic β-cells is protective against high fat diet-induced diabetes.

Jamie W. Joseph,É. Bombardier,S. Paglialunga,M. Hoang,A. R. Tupling
DOI: https://doi.org/10.1210/en.2018-00936
IF: 5.051
2019-10-03
Endocrinology
Abstract:The transcription factor aryl hydrocarbon receptor nuclear translocator (ARNT)/hypoxia-inducible factor (HIF)-1β (ARNT/HIF1β) plays a key role in maintaining β-cell function and has been shown to be one of the most down regulated transcription factors in islets from type 2 diabetic patients. We have shown a role for ARNT/HIF1β in glucose sensing and insulin secretion in vitro and no defects in in vivo glucose homeostasis. In order to gain a better understanding of the role of ARNT/HIF1β in the development of diabetes, we placed control (+/+/Cre) and β-cell specific ARNT/HIF1β knockout (fl/fl/Cre) mice on a high fat (HF) diet. Unlike the control (+/+/Cre) mice, fl/fl/Cre mice on a HF diet had no impairment in in vivo glucose tolerance. The lack of impairment in HF fed fl/fl/Cre mice was partly due to an improved islet glucose-stimulated NADPH/NADP+ ratio and glucose-stimulated insulin secretion (GSIS). The effects of the HF diet rescued insulin secretion in fl/fl/Cre islets could be reproduced by treating low fat diet fed fl/fl/Cre islets with the lipid signalling molecule 1-monoacylglcyerol. This suggests that the defects seen in low fat diet fed fl/fl/Cre islet insulin secretion involves lipid signalling molecules. Overall, mice lacking ARNT/HIF1β in β-cells have altered lipid signalling in vivo and are resistant to a HF diets ability to induce diabetes.
Medicine,Biology,Chemistry
What problem does this paper attempt to address?